IL136977A0 - Novel optically active aminopentane derivatives - Google Patents
Novel optically active aminopentane derivativesInfo
- Publication number
- IL136977A0 IL136977A0 IL13697799A IL13697799A IL136977A0 IL 136977 A0 IL136977 A0 IL 136977A0 IL 13697799 A IL13697799 A IL 13697799A IL 13697799 A IL13697799 A IL 13697799A IL 136977 A0 IL136977 A0 IL 136977A0
- Authority
- IL
- Israel
- Prior art keywords
- optically active
- novel optically
- disease
- composition
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP34775698A JP4499208B2 (ja) | 1998-10-29 | 1998-10-29 | 新規な光学活性アミノペンタン誘導体 |
| PCT/JP1999/005729 WO2000026204A1 (fr) | 1998-10-29 | 1999-10-15 | Nouveau derive d'aminopentane optiquement actif |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL136977A0 true IL136977A0 (en) | 2001-06-14 |
Family
ID=18392375
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13697799A IL136977A0 (en) | 1998-10-29 | 1999-10-15 | Novel optically active aminopentane derivatives |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6391914B1 (ja) |
| EP (1) | EP1052259B1 (ja) |
| JP (1) | JP4499208B2 (ja) |
| KR (1) | KR100603112B1 (ja) |
| CN (1) | CN1131858C (ja) |
| AT (1) | ATE360009T1 (ja) |
| AU (1) | AU762995B2 (ja) |
| CA (1) | CA2317036C (ja) |
| DE (1) | DE69935849T2 (ja) |
| DK (1) | DK1052259T3 (ja) |
| ES (1) | ES2285861T3 (ja) |
| HK (1) | HK1032585A1 (ja) |
| HU (1) | HU228299B1 (ja) |
| IL (1) | IL136977A0 (ja) |
| PT (1) | PT1052259E (ja) |
| SI (1) | SI20209A (ja) |
| WO (1) | WO2000026204A1 (ja) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4691230B2 (ja) * | 2000-04-11 | 2011-06-01 | 株式会社フジモト・コーポレーション | 光学活性１−（ベンゾフラン−２−イル）−２−プロピルアミノペンタンの製造方法 |
| JP4888751B2 (ja) * | 2001-09-14 | 2012-02-29 | 株式会社フジモト・コーポレーション | トリフルオロプロピルアミノペンタン誘導体及びその製造方法 |
| JP4953040B2 (ja) * | 2001-09-19 | 2012-06-13 | 株式会社フジモト・コーポレーション | アポトーシス抑制剤 |
| JP5030194B2 (ja) * | 2004-11-25 | 2012-09-19 | 国立大学法人九州大学 | 薬物依存症治療剤 |
| CA2690945C (en) * | 2007-06-21 | 2015-07-21 | Fujimoto Co., Ltd. | Transdermal or transmucosal pharmaceutical composition comprising 1-(benzofuran-2-yl)-2-propylaminopentane |
| SI3087984T1 (sl) * | 2013-12-25 | 2021-08-31 | Fujimoto Co., Ltd. | Profilaktično in terapevtsko sredstvo za motnjo pomanjkanja pozornosti s hiperaktivnostjo |
| RU2714893C2 (ru) | 2014-12-05 | 2020-02-20 | Земмельвайс Юнивёрсити | Арилалкиламиновые соединения для применения для профилактики или лечения рака |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU207280B (en) * | 1986-09-25 | 1993-03-29 | Chinoin Gyogyszer Es Vegyeszet | Process for producing new phenyl-alkyl-amines and pharmaceutical compositions containing them |
| HUT63579A (en) * | 1991-12-20 | 1993-09-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes |
| JPH0859578A (ja) * | 1994-06-17 | 1996-03-05 | Taisho Pharmaceut Co Ltd | 置換フェニルアルキルアミン誘導体 |
| CA2267315C (en) * | 1997-08-07 | 2008-01-08 | Fujimoto Brothers Co., Ltd. | Ethylamine derivatives |
-
1998
- 1998-10-29 JP JP34775698A patent/JP4499208B2/ja not_active Expired - Fee Related
-
1999
- 1999-10-15 CN CN998018570A patent/CN1131858C/zh not_active Expired - Fee Related
- 1999-10-15 WO PCT/JP1999/005729 patent/WO2000026204A1/ja active IP Right Grant
- 1999-10-15 EP EP99947940A patent/EP1052259B1/en not_active Expired - Lifetime
- 1999-10-15 AT AT99947940T patent/ATE360009T1/de active
- 1999-10-15 IL IL13697799A patent/IL136977A0/xx not_active IP Right Cessation
- 1999-10-15 KR KR1020007007280A patent/KR100603112B1/ko not_active IP Right Cessation
- 1999-10-15 PT PT99947940T patent/PT1052259E/pt unknown
- 1999-10-15 AU AU61241/99A patent/AU762995B2/en not_active Ceased
- 1999-10-15 DE DE69935849T patent/DE69935849T2/de not_active Expired - Lifetime
- 1999-10-15 SI SI9920013A patent/SI20209A/sl not_active IP Right Cessation
- 1999-10-15 CA CA002317036A patent/CA2317036C/en not_active Expired - Fee Related
- 1999-10-15 HU HU0004667A patent/HU228299B1/hu not_active IP Right Cessation
- 1999-10-15 ES ES99947940T patent/ES2285861T3/es not_active Expired - Lifetime
- 1999-10-15 US US09/581,747 patent/US6391914B1/en not_active Expired - Lifetime
- 1999-10-15 DK DK99947940T patent/DK1052259T3/da active
-
2001
- 2001-05-08 HK HK01103235A patent/HK1032585A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1287554A (zh) | 2001-03-14 |
| ES2285861T3 (es) | 2007-11-16 |
| DK1052259T3 (da) | 2007-08-06 |
| PT1052259E (pt) | 2007-07-20 |
| CN1131858C (zh) | 2003-12-24 |
| KR20010033756A (ko) | 2001-04-25 |
| HUP0004667A3 (en) | 2001-10-29 |
| DE69935849D1 (de) | 2007-05-31 |
| EP1052259A4 (en) | 2001-10-24 |
| ATE360009T1 (de) | 2007-05-15 |
| AU762995B2 (en) | 2003-07-10 |
| AU6124199A (en) | 2000-05-22 |
| JP2000136187A (ja) | 2000-05-16 |
| WO2000026204A1 (fr) | 2000-05-11 |
| SI20209A (sl) | 2000-10-31 |
| HUP0004667A2 (hu) | 2001-04-28 |
| EP1052259A1 (en) | 2000-11-15 |
| CA2317036A1 (en) | 2000-05-11 |
| JP4499208B2 (ja) | 2010-07-07 |
| HK1032585A1 (en) | 2001-07-27 |
| CA2317036C (en) | 2009-05-19 |
| HU228299B1 (en) | 2013-03-28 |
| EP1052259B1 (en) | 2007-04-18 |
| KR100603112B1 (ko) | 2006-07-20 |
| DE69935849T2 (de) | 2008-01-10 |
| US6391914B1 (en) | 2002-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9914638A (pt) | Composto, método para a preparação do mesmo, composição farmacêutica, uso de um composto, e, método para o tratamento de um distúrbio ou doença de um corpo de animal vivo | |
| MY138252A (en) | Azabicyclic-substitud fused-heteroaryl compounds for the treatment of disease | |
| NO20063275L (no) | Anvendelse av substituerte 2-aminotetraliner for forebyggende behandling av Parkinsons sykdom | |
| BG105112A (en) | Agents with antidepressive effect | |
| ATE260255T1 (de) | 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate | |
| GB0318447D0 (en) | Therapeutic agents | |
| ES2196527T3 (es) | Derivados de 11,15-o-dialquilprostaglandina e, su procedimiento de produccion y medicamentos que incluyen estos como principio activo. | |
| JO2372B1 (en) | Source drugs of 4-phenylpyridine derivatives | |
| GB0225475D0 (en) | Therapeutic agents | |
| PT669920E (pt) | 3-aminoalquilamino-1,2-benzoxazoles substituidos ecompostos relacionados | |
| ATE272398T1 (de) | Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz | |
| BR0206495A (pt) | Tratamento de distúrbios de cns empregando antagonistas de oxidase de d-aminoácido e oxidase de d-aspartato | |
| NO20021875L (no) | Fremgangsmåte for stabilisering av benzimidazolforbindelser | |
| MX2009004898A (es) | Derivados de indol y de benzofurano-2-carboxamida. | |
| IL136977A0 (en) | Novel optically active aminopentane derivatives | |
| ATE330930T1 (de) | Neue ethylaminderivate | |
| HUP0302478A2 (hu) | Modafinil-vegyületek gyógyszerészeti oldatai | |
| BR0011728A (pt) | Método de inibir a agregação de proteìna amilóide e imagem de depósitos de amilóide | |
| DK0966277T3 (da) | Anvendelse af R-NSAID'er til forebyggelse af Alzheimer's sygdom | |
| DK1174131T3 (da) | Anvendelse af et middel til forbedring af astrocytfunktion til behandling af Parkinsons sygdom | |
| BR0110871A (pt) | Derivados de sulfonamida | |
| PT804186E (pt) | Compostos alcaloides diterpenicos de indole | |
| AU2003213896A1 (en) | Process to obtain dibenzylbutyrolactonic lignans; process to obtain synthetic derivatives from lignanes bearing anti-chagas chemoprophylactic and therapeutical activities | |
| BR0110874A (pt) | Derivados de sulfonamida | |
| CA2270026A1 (en) | Substituted bicyclic derivatives for treating central nervous system disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |